Massachusetts Financial Services’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.6M Buy
799,186
+85,332
+12% +$2.52M 0.01% 591
2025
Q1
$21.3M Buy
713,854
+109,655
+18% +$3.27M 0.01% 593
2024
Q4
$17.3M Sell
604,199
-161,493
-21% -$4.63M 0.01% 615
2024
Q3
$29.6M Buy
765,692
+116,327
+18% +$4.49M 0.01% 539
2024
Q2
$20.9M Sell
649,365
-12,433
-2% -$400K 0.01% 574
2024
Q1
$25.7M Sell
661,798
-3,320
-0.5% -$129K 0.01% 547
2023
Q4
$20.5M Buy
665,118
+599
+0.1% +$18.4K 0.01% 568
2023
Q3
$14.9M Buy
664,519
+1,136
+0.2% +$25.4K 0.01% 597
2023
Q2
$14.3M Sell
663,383
-6,104
-0.9% -$131K ﹤0.01% 581
2023
Q1
$16.1M Sell
669,487
-150,125
-18% -$3.6M 0.01% 572
2022
Q4
$19M Buy
819,612
+2,686
+0.3% +$62.3K 0.01% 554
2022
Q3
$13.1M Sell
816,926
-53,380
-6% -$855K ﹤0.01% 593
2022
Q2
$15.4M Buy
870,306
+5,524
+0.6% +$97.9K 0.01% 578
2022
Q1
$17.6M Buy
864,782
+22,401
+3% +$456K 0.01% 597
2021
Q4
$15.7M Buy
842,381
+20,634
+3% +$385K ﹤0.01% 626
2021
Q3
$16.2M Sell
821,747
-10,807
-1% -$213K ﹤0.01% 631
2021
Q2
$19.7M Buy
832,554
+189,232
+29% +$4.47M 0.01% 617
2021
Q1
$15.2M Sell
643,322
-16,417
-2% -$389K ﹤0.01% 633
2020
Q4
$13.2M Buy
659,739
+9,940
+2% +$199K ﹤0.01% 625
2020
Q3
$13.5M Sell
649,799
-17,119
-3% -$356K ﹤0.01% 605
2020
Q2
$11.7M Buy
666,918
+183,352
+38% +$3.21M ﹤0.01% 592
2020
Q1
$7.9M Sell
483,566
-10,572
-2% -$173K ﹤0.01% 607
2019
Q4
$10.2M Sell
494,138
-94,007
-16% -$1.93M ﹤0.01% 602
2019
Q3
$6.75M Sell
588,145
-2,247
-0.4% -$25.8K ﹤0.01% 637
2019
Q2
$7.76M Buy
590,392
+3,450
+0.6% +$45.4K ﹤0.01% 643
2019
Q1
$8.89M Sell
586,942
-76,556
-12% -$1.16M ﹤0.01% 626
2018
Q4
$11.4M Buy
663,498
+13,874
+2% +$238K 0.01% 578
2018
Q3
$9.58M Buy
649,624
+229,968
+55% +$3.39M ﹤0.01% 632
2018
Q2
$10M Buy
419,656
+5,818
+1% +$139K ﹤0.01% 626
2018
Q1
$10.6M Sell
413,838
-35,427
-8% -$905K ﹤0.01% 603
2017
Q4
$8.29M Sell
449,265
-223,362
-33% -$4.12M ﹤0.01% 636
2017
Q3
$7.06M Buy
672,627
+4,069
+0.6% +$42.7K ﹤0.01% 636
2017
Q2
$8.36M Buy
668,558
+28,369
+4% +$355K ﹤0.01% 623
2017
Q1
$6.44M Buy
640,189
+191,062
+43% +$1.92M ﹤0.01% 629
2016
Q4
$6.99M Sell
449,127
-59,868
-12% -$932K ﹤0.01% 632
2016
Q3
$9.8M Buy
508,995
+8,686
+2% +$167K ﹤0.01% 575
2016
Q2
$5.93M Buy
500,309
+138,305
+38% +$1.64M ﹤0.01% 628
2016
Q1
$6.57M Buy
362,004
+4,420
+1% +$80.2K ﹤0.01% 614
2015
Q4
$9.83M Sell
357,584
-2,382
-0.7% -$65.5K 0.01% 590
2015
Q3
$7.96M Sell
359,966
-128,544
-26% -$2.84M ﹤0.01% 621
2015
Q2
$8.72M Buy
+488,510
New +$8.72M ﹤0.01% 622